A Randomized Comparative Clinical Study on Efficacy of Visaghna (anti poison) Mahakasaya-Ghanavati(poly herbal drug) and Haridrakhanda(herbo-mineral drug) in Sitapitta with the special reference of urticaria

A Randomized Comparative Clinical Study On Efficacy Of Visaghna - Mahakasaya-Ghanavati And Haridrakhanda In Sitapitta In The Purview Cikitsaya Visaghnyaiva Sa Samam Labhate Narah - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/066733

Enrollment

Registered

2024-05-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients between the age group 18-60 years of age Patients of either gender The patients having classical signs and symptoms of Sitapitta Patients willing to participate in the clinical trial

Exclusion criteria

Exclusion criteria: Patient with long term history of steroid and cytotoxic treatment Pregnant and lactating women Patients having concomitant illness like uncontrolled Hypertension uncontrolled Diabetes mellitus HIV Malignancy etc Anaphylaxis Angioedema of the lips tongue or larynx etc

Design outcomes

Primary

Measure	Time frame
Primary Outcome Change in classical symptoms of sheetpitta such as Wheals or hives Itching Prickling sensation Nausea or vomitting Fever Burning sensation Timepoint: 30days	—

Secondary

Measure	Time frame
Change in IgE DLC ESRTimepoint: 30 days	—

Countries

India

Contacts

Public ContactManisha Mehta

National Institute of Ayurveda

Guptadr.nisha@gmail.com9828087640

Outcome results